Sutro Biopharma (STRO) Other Non-Current Assets (2016 - 2026)

Sutro Biopharma has reported Other Non-Current Assets for 10 years, with the latest figure at $858000.0 in Q4 2025.

• Quarterly Other Non-Current Assets fell 4.67% year-over-year to $858000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $858000.0 (down 4.67% YoY) and the FY2025 annual result came in at $858000.0, down 4.67% from the prior year.
• Other Non-Current Assets held at $858000.0 in Q4 2025 per STRO's latest filing, from $858000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $900000.0 in Q4 2024 and troughed at $857000.0 in Q1 2024.
• A 5-year average of $868894.7 and a median of $872000.0 in 2021 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2021 and 2025: Other Non-Current Assets soared 5713.33% in 2021, then slipped 4.67% in 2025.
• Over 5 years, Other Non-Current Assets stood at $872000.0 in 2021, then changed by 0.0% to $872000.0 in 2022, then changed by 0.0% to $872000.0 in 2023, then gained by 3.21% to $900000.0 in 2024, then retreated by 4.67% to $858000.0 in 2025.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $858000.0, $858000.0, and $858000.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.